Table 1

Participant characteristics

CharacteristicsResults
Participants, n72
RaceAfrican-American
Eyes included for analysis72 (one eye per each participant)
Median age and range (years)32.5; range 19–70
Female, n (%)46 (63.9)
Right eye included, n (%)42 (58)
Controls, n20
Patients with sickle cell disease, n52
 Stratified by proliferative disease, n (%)
 Non-proliferative (stage 2 or below)33 (63.5)
 Proliferative (stage 3 or above)19 (36.5)
 Stratified by sickle genotype, n (%)
 Haemoglobin SS35 (67.3)
 Haemoglobin SC10 (19.2)
 Beta-thalassemia7 (13.5)